Announcements Trials
Browse Landscape

Phase

Phase NA 1

Status

Unknown 2Terminated 1Suspended 1Recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Other 1

Conditions

Obesity 60Neoplasms 20Overweight 17Polycystic Ovary Syndrome 11Dyspnea 10Sexual Dysfunction, Physiological 9Prostatic Neoplasms 7Motor Activity 7Hypertension 7Endometrial Neoplasms 7Breast Neoplasms 7Diabetes Mellitus, Type 2 6Mucositis 5Metabolic Syndrome 5Diabetes Mellitus 5Pulmonary Disease, Chronic Obstructive 4Lung Neoplasms 4Depression 4Constipation 4Cardiovascular Diseases 4Weight Loss 3Stomatitis 3Renal Insufficiency, Chronic 3Precursor Cell Lymphoblastic Leukemia-Lymphoma 3Opioid-Induced Constipation 3Non-alcoholic Fatty Liver Disease 3Myasthenia Gravis 3Insulin Resistance 3Heart Failure 3Endometrial Hyperplasia 3

Interventions

Nutrition Assessment 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Recruiting × Hypercholesterolemia × Other × Clear all
NCT07126587 2025-10-30

HLA

University of North Carolina, Chapel Hill

Phase NA Recruiting
120 enrolled
Other

Diabetes Mellitus, Type 2, Heart Diseases, Hypercholesterolemia, Hypertension, Neoplasms, Obesity, Overweight

Data powered by HemOnc (CC BY 4.0) Colophon âš¡